MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson’s Disease and Type 2 Diabetes

YJ. Bae, C. Shin, H. Jeong, SJ. Cho, SH. Baik, DH. Lee, Y. Jeong, JM. Kim (Gainesville, USA)

Meeting: 2026 International Congress

Keywords: Magnetic resonance imaging(MRI), Parkinson’s

Category: Parkinson's disease: Neuroimaging

Objective: This study aimed to investigate the differences in perivascular water diffusivity and structural neurofluid markers using diffusion tensor image-analysis along the perivascular space (DTI-ALPS), perivascular space (PVS) burden, and choroid plexus volume (CPV) in Parkinson’s disease (PD) and type 2 diabetes mellitus (T2DM).

Background: Alterations in perivascular fluid dynamics has been implicated in PD and metabolic disorders such as T2DM. However, the relative contributions of neurodegenerative and metabolic conditions to functional perivascular water diffusivity versus structural neurofluid markers remains to be elucidated.

Method: In this retrospective study, consecutive patients diagnosed with de novo idiopathic PD and disease control subjects who underwent 3T brain MRI between May 2017 and May 2023 were included. Subjects were classiifed into four groups according to PD and T2DM status and matched for age and sex. Perivascular water diffusivity was assessed using ALPS-index, and PVS burden and CPV were quantified on three-dimensional T1-weighted images and normalized to intracranial volume. Group differences were evaluated using analysis of variance with post hoc testing.

Results: A total of 132 subjects were included. The ALPS-index differed significantly among the four groups (P < 0.001), with both PD groups demonstrating significantly lower values than control groups, regardless of T2DM status: controls without T2DM (1.52 ± 0.10), controls with T2DM (1.49 ± 0.12), PD without T2DM (1.35 ± 0.11), and PD with T2DM (1.33 ± 0.10). No significant differences in the ALPS-index were observed between subjects with and without T2DM within the same diagnosis. Within the PD cohort, longer disease duration and older age were independently associated with lower ALPS-index values. CPV normalized to intracranial volume also differed significantly across group (P = 0.012) with higher values observed only in controls with T2DM, while PVS burden did not differ significantly.

Conclusion: In early-stage PD, impaired perivascular diffusivity was driven primarily by neurodegeneration, with no additive effect from T2DM. Conversely, choroid plexus remodeling reflected an interactive pattern where metabolic hypertrophy was attenuated in the presence of PD. These findings highlight a dissociation between functional fluid dynamics and structural neurofluid markers in the early disease stage.

To cite this abstract in AMA style:

YJ. Bae, C. Shin, H. Jeong, SJ. Cho, SH. Baik, DH. Lee, Y. Jeong, JM. Kim. Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson’s Disease and Type 2 Diabetes [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/distinct-patterns-of-perivascular-diffusivity-and-choroid-plexus-volume-in-de-novo-parkinsons-disease-and-type-2-diabetes/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/distinct-patterns-of-perivascular-diffusivity-and-choroid-plexus-volume-in-de-novo-parkinsons-disease-and-type-2-diabetes/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley